Reduced-intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in neuroblastoma either refractory or relapsed after autologous stem cell transplantation

被引：0
|
作者：
Prete, A.
Rondelli, R.
Lanino, E.
Pession, A.
Locatelli, F.
Zecca, M.
Messina, C.
Caselli, D.
Favre, C.
Rabusin, M.
Fagioli, F.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen
    Ayuk, Francis
    Zabelina, Tatjana
    Bacher, Ulrike
    Wolschke, Christine
    Lellek, Heinrich
    Eiermann, Thomas
    Erttmann, Rudolf
    Kroeger, Nicolaus
    Zander, Axel R.
    BLOOD, 2009, 114 (22) : 1317 - 1318
  • [22] Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma
    S Yano
    T Mori
    Y Kanda
    J Kato
    C Nakaseko
    S Fujisawa
    N Tomita
    R Sakai
    K Shono
    T Saitoh
    N Aotsuka
    N Kobayashi
    T Saito
    S Takahashi
    H Kanamori
    S Okamoto
    Bone Marrow Transplantation, 2015, 50 : 1299 - 1305
  • [23] Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma
    Yano, S.
    Mori, T.
    Kanda, Y.
    Kato, J.
    Nakaseko, C.
    Fujisawa, S.
    Tomita, N.
    Sakai, R.
    Shono, K.
    Saitoh, T.
    Aotsuka, N.
    Kobayashi, N.
    Saito, T.
    Takahashi, S.
    Kanamori, H.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 (10) : 1299 - 1305
  • [24] Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method
    Homero Gutierrez-Aguirre, Cesar
    Ruiz-Arguelles, Guillermo
    Graciela Cantu-Rodriguez, Olga
    Gonzalez-Llano, Oscar
    Carlos Jaime-Perez, Jose
    Garcia-Rodriguez, Fernando
    Lopez-Otero, Avril
    Luis Herrera-Garza, Jose
    Gomez-Almaguer, David
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1045 - 1052
  • [25] Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method
    Cesar Homero Gutiérrez-Aguirre
    Guillermo Ruiz-Argüelles
    Olga Graciela Cantú-Rodríguez
    Oscar González-Llano
    José Carlos Jaime-Pérez
    Fernando García-Rodríguez
    Avril López-Otero
    José Luis Herrera-Garza
    David Gómez-Almaguer
    Annals of Hematology, 2010, 89 : 1045 - 1052
  • [26] Allogeneic stem cell transplantation with reduced-intensity conditioning regimen:: incidence and risk factors for conditioning related toxicities
    Subirà, M
    Ancín, I
    Sureda, A
    Martino, R
    Altés, A
    Brunet, S
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S146 - S146
  • [27] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    A. Sureda
    N. Schmitz
    Annals of Hematology, 2003, 82 : 1 - 13
  • [28] Reduced-intensity regimen for unrelated donor transplantation (UDT) as salvage therapy for prior recipients of autologous stem cell transplantation.
    Ratanatharathorn, V
    Ayash, L
    Silver, S
    Reynolds, C
    Becker, M
    Reddy, P
    Uberti, JP
    BLOOD, 2003, 102 (11) : 491A - 491A
  • [29] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease
    Martin-Salces, M
    de la Guía, AL
    Hernández, D
    Kerguelén, A
    Cobo, T
    Canales, M
    G-Bustos, J
    Hernández-Navarro, F
    BONE MARROW TRANSPLANTATION, 2006, 37 : S323 - S323
  • [30] Recombinant erythropoietin after reduced-intensity conditioning for allogeneic stem cell transplantation
    Blaise, D
    Ivanov, V
    Bilger, K
    Faucher, C
    Mohty, M
    Ladaique, P
    Sainty, D
    Chabannon, C
    Vey, N
    Maraninchi, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S327 - S328
12345